| Bioactivity | Dansyl-Gly-Cys-Val-Leu-Ser TFA is a dansyl-labeled peptide[1]. | ||||||
| Name | Dansyl-Gly-Cys-Val-Leu-Ser TFA | ||||||
| Sequence | {Dansyl}-Gly-Cys-Val-Leu-Ser | ||||||
| Shortening | {Dansyl}-GCVLS | ||||||
| Formula | C31H46N6O9S2.xC2HF3O2 | ||||||
| Molar Mass | 710.86 (free base) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||
| Reference | [1]. Eckert GP, et, al. Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis. 2009 Aug;35(2):251-7. |